Loading...

Summerset Group Holdings Limited

SNZ.AXASX
Healthcare
Medical - Care Facilities
A$10.35
A$0.05(0.49%)

Summerset Group Holdings Limited (SNZ.AX) Financial Performance & Income Statement Overview

View comprehensive annual and quarterly summaries for Summerset Group Holdings Limited (SNZ.AX), featuring income statements, balance sheets, and cash flow data.

Revenue Growth
17.79%
17.79%
Operating Income Growth
-100.00%
100.00%
Net Income Growth
-22.11%
22.11%
Operating Cash Flow Growth
-100.00%
100.00%
Operating Margin
44.85%
44.85%
Gross Margin
45.60%
45.60%
Net Profit Margin
137.79%
137.79%
ROE
14.31%
14.31%
ROIC
1.73%
1.73%

Summerset Group Holdings Limited (SNZ.AX) Income Statement & Financial Overview

Explore comprehensive income reports for Summerset Group Holdings Limited SNZ.AX, broken down by year and quarter.

MetricQ2 2024Q4 2023Q2 2023Q4 2022
Revenue$151.05M$142.25M$128.25M$124.16M
Cost of Revenue$137.33M$136.30M$111.69M$109.81M
Gross Profit$13.72M$5.96M$16.56M$14.36M
Gross Profit Ratio$0.09$0.04$0.13$0.12
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$0.00$0.00$0.00$290000.00
Operating Expenses-$119.80M-$303.31M$124.14M$136.93M
Total Costs & Expenses$17.54M-$167.01M$235.83M$246.74M
Interest Income$0.00$2.41M$12.60M$21.09M
Interest Expense$0.00$0.00$0.00$0.00
Depreciation & Amortization$9.18M$5.43M$7.35M$4.36M
EBITDA$13.72M$2.94M$16.56M$11.73M
EBITDA Ratio$0.09$0.02$0.13$0.09
Operating Income$133.52M$309.27M$9.21M$7.37M
Operating Income Ratio$0.88$2.17$0.07$0.06
Other Income/Expenses (Net)-$12.76M-$14.90M-$12.60M-$9.69M
Income Before Tax$120.76M$294.37M$128.11M$130.20M
Income Before Tax Ratio$0.80$2.07$1.00$1.05
Income Tax Expense$18.60M$8.89M$4.95M$4.24M
Net Income$102.16M$303.26M$133.06M$134.43M
Net Income Ratio$0.68$2.13$1.04$1.08
EPS$0.44$1.30$0.57$0.58
Diluted EPS$0.43$1.30$0.57$0.58
Weighted Avg Shares Outstanding$234.62M$233.80M$232.62M$231.78M
Weighted Avg Shares Outstanding (Diluted)$235.02M$233.80M$232.62M$231.74M

The company's financials show resilient growth, with revenue advancing from $124.16M in Q4 2022 to $151.05M in Q2 2024. Gross profit remained healthy with margins at 9% in Q2 2024 compared to 12% in Q4 2022. Operating income hit $133.52M last quarter, sustaining a consistent 88% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $13.72M. Net income dropped to $102.16M, while earnings per share reached $0.44. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;